NRC Health (NRC)
NASDAQ: NRC · Real-Time Price · USD
19.53
-0.13 (-0.66%)
May 29, 2026, 4:00 PM EDT - Market closed
NRC Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 440 | 425 | 407 | 958 | 919 | 1,053 | |
Market Cap Growth | 44.26% | 4.35% | -57.50% | 4.30% | -12.76% | -2.99% |
Enterprise Value | 515.63 | 495.78 | 460.85 | 980.96 | 911.3 | 1,021 |
Last Close Price | 19.53 | 18.77 | 17.64 | 39.56 | 37.30 | 41.52 |
PE Ratio | 50.72 | 37.54 | 16.96 | 31.65 | 29.37 | 28.44 |
Forward PE | - | 34.39 | 34.39 | 34.39 | 34.39 | 34.39 |
PEG Ratio | - | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 |
PS Ratio | 3.17 | 3.09 | 2.85 | 6.45 | 6.06 | 7.12 |
PB Ratio | 32.62 | 30.37 | 13.02 | 19.57 | 12.75 | 12.34 |
P/TBV Ratio | 32.02 | 30.05 | 13.39 | 19.94 | 12.97 | 12.48 |
P/FCF Ratio | 25.25 | 26.99 | 21.23 | 42.90 | 34.76 | 25.79 |
P/OCF Ratio | 16.31 | 16.06 | 11.76 | 25.14 | 25.33 | 22.72 |
EV/Sales Ratio | 3.72 | 3.61 | 3.22 | 6.60 | 6.01 | 6.90 |
EV/EBITDA Ratio | 14.90 | 16.41 | 11.18 | 21.35 | 17.59 | 18.02 |
EV/EBIT Ratio | 19.57 | 21.95 | 13.09 | 24.50 | 19.58 | 20.31 |
EV/FCF Ratio | 29.58 | 31.49 | 24.03 | 43.92 | 34.48 | 25.00 |
Debt / Equity Ratio | 5.48 | 5.36 | 1.85 | 0.60 | 0.25 | 0.26 |
Debt / EBITDA Ratio | 2.81 | 2.62 | 1.52 | 0.80 | 0.43 | 0.47 |
Debt / FCF Ratio | 4.48 | 5.02 | 3.27 | 1.64 | 0.84 | 0.65 |
Net Debt / Equity Ratio | 5.59 | 5.35 | 1.87 | 0.61 | -0.04 | -0.33 |
Net Debt / EBITDA Ratio | 2.71 | 2.48 | 1.42 | 0.65 | -0.05 | -0.49 |
Net Debt / FCF Ratio | 4.33 | 4.76 | 3.05 | 1.35 | -0.11 | -0.68 |
Asset Turnover | 1.03 | 1.03 | 1.12 | 1.18 | 1.05 | 1.02 |
Quick Ratio | 0.36 | 0.43 | 0.43 | 0.53 | 1.20 | 1.70 |
Current Ratio | 0.52 | 0.55 | 0.55 | 0.67 | 1.31 | 1.82 |
Return on Equity (ROE) | 65.75% | 51.24% | 61.77% | 51.20% | 40.41% | 50.07% |
Return on Assets (ROA) | 9.05% | 10.98% | 20.93% | 24.54% | 24.01% | 26.63% |
Return on Invested Capital (ROIC) | 10.16% | 12.41% | 23.94% | 30.82% | 37.49% | 43.86% |
Return on Capital Employed (ROCE) | 20.13% | 23.18% | 38.48% | 43.70% | 43.46% | 45.93% |
Earnings Yield | 1.95% | 2.66% | 5.90% | 3.16% | 3.40% | 3.52% |
FCF Yield | 3.96% | 3.71% | 4.71% | 2.33% | 2.88% | 3.88% |
Dividend Yield | 3.28% | 2.61% | 2.74% | 3.75% | 2.25% | 0.87% |
Payout Ratio | 155.81% | 94.64% | 46.21% | 117.42% | 65.92% | 24.45% |
Buyback Yield / Dilution | 5.81% | 5.67% | 3.77% | 1.51% | 2.29% | 0.22% |
Total Shareholder Return | 9.09% | 8.29% | 6.51% | 5.26% | 4.55% | 1.09% |